top of page
2025
Adoption of microfluidic MEA technology for electrophysiology of 3D neuronal networks exposed to suborbital conditions. Link


2024
Fibrin-polycaprolactone scaffolds for the differentiation of human neural progenitor cells into dopaminergic neurons. Link

Materials Characterization of Stereolithography 3D Printed Polymer to Develop a Self-Driven Microfluidic Device for Bioanalytical Applications. Link
​
2023
Microcomputed Tomography for the Microstructure Evaluation of 3D Bioprinted Scaffolds. Link
​
Inhibition of ERK 1/2 pathway downregulates YAP1/TAZ signaling in human cardiomyocytes exposed to hyperglycemic conditions. Link

Development of in vitro cardiovascular tissue models within capillary circuit microfluidic devices fabricated with 3D stereolithography printing. Link

​

bottom of page